Results 71 to 80 of about 146,442,143 (129)

Study of the indications for macrolide prescriptions in a Colombian population [PDF]

open access: yesBiomedica, 2022
Valladales-Restrepo LF   +6 more
europepmc   +1 more source

Bol CIM 223 : Utilización de medicamentos en insuficiencia renal

open access: yes, 2016
Fil: Centro de Información de Medicamentos (CIM). Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas.
Centro de Información de Medicamentos - FCByF - UNR
core  

[Drug Excipients. Necessary, but not Harmless]. [PDF]

open access: yesFarm Comunitarios
López Alarcón MD   +2 more
europepmc   +1 more source

Prevalencia de reacciones de hipersensibilidad a quimioterapia y agentes biológicos en pacientes del hospital universitario Dr. José Eleuterio González [PDF]

open access: yes
Introducción: Los agentes biológicos y quimioterapéuticos, son utilizados en el tratamiento de un gran número de patologías, en especial aquellas de carácter inflamatorio y neoplásico.
Reyna Tobías, Luis Obeth
core  

Medicines withdrawn in other countries due to safety problems, between 2014 and 2023, and their permanence in the Argentine market. [PDF]

open access: yesRev Fac Cien Med Univ Nac Cordoba
Caffaratti M   +9 more
europepmc   +1 more source

Consensus document on anemia and iron deficiency in heart failure: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) of the Interamerican Society of Cardiology (IASC). [PDF]

open access: yesArch Cardiol Mex, 2023
Speranza M   +16 more
europepmc   +1 more source

Characterization of the safety notes of pharmaceutical products issued by two regulatory authorities from Latin America. [PDF]

open access: yesRev Peru Med Exp Salud Publica
Pérez-Salazar K   +2 more
europepmc   +1 more source

[Frequency of cutaneous drug reactions in the outpatient dermatology clinic at the National Institute of Cardiology Ignacio Chávez over a ten-year period]. [PDF]

open access: yesArch Cardiol Mex
Coria-Vázquez S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy